Research
Energy balance
Experience with GLP-1 agonists in patients with obesity and inflammatory skin diseases is currently scarce.
Further research is needed to establish the efficacy and safety of GLP-1 agonists in this specific population.
StrongSupportsmedium confidence
Although experience with GLP-1 agonists in patients with obesity and inflammatory skin diseases is currently scarce.
Why this rating
The claim is based on the authors' review of existing literature.
Source
[Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases
Eva Vilarrasa et al. · Actas Dermo-Sifiliográficas · 2023
DOI 10.1016/j.ad.2023.10.019
reviewCited 5×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →